Selvita completes acquisition of PozLab and significantly expands its drug development capabilities
Go back to Selvita completes acquisition of PozLab and significantly expands its drug development capabilities| ISHARES SILVER TRUST (NYSE: SLV) | Delayed: 62.72 +1.06 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.66 | 52 Week High | $19.71 | |||
| Open | $62.90 | 52 Week Low | $13.04 | |||
| Day High | $63.21 | P/E | N/A | |||
| Day Low | $62.26 | EPS | $0.00 | |||
| Volume | 22,820,892 | |||||
| ISHARES SILVER TRUST (NYSE: SLV) | Delayed: 62.72 +1.06 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.66 | 52 Week High | $19.71 | |||
| Open | $62.90 | 52 Week Low | $13.04 | |||
| Day High | $63.21 | P/E | N/A | |||
| Day Low | $62.26 | EPS | $0.00 | |||
| Volume | 22,820,892 | |||||
